Malignant glioma – Life with Disease

Go back

Malignant glioma represents one of the most aggressive forms of brain cancer, affecting thousands of people each year and presenting profound challenges not only for patients but also for their families and medical teams.

Understanding the Prognosis of Malignant Glioma

When someone receives a diagnosis of malignant glioma, one of the first questions that naturally comes to mind concerns what lies ahead. Understanding the prognosis of this condition requires both sensitivity and honesty, as these tumors are among the most serious forms of brain cancer that doctors encounter today.[1]

Malignant gliomas are high-grade brain tumors, meaning they grow rapidly and behave aggressively. The term “high-grade” refers to how abnormal the tumor cells appear under a microscope and how quickly they multiply. These tumors comprise several types, including anaplastic oligodendroglioma, anaplastic astrocytoma, and the most aggressive form, glioblastoma.[3]

The outlook for people with malignant gliomas varies significantly depending on the specific type of tumor, its location in the brain, the person’s age, overall health, and how much of the tumor can be safely removed during surgery. For glioblastoma, which is the most common and aggressive type, the median survival ranges from 9 to 12 months despite receiving the maximum treatment available. This sobering statistic has remained relatively unchanged over several decades, despite significant advances in neurosurgery and other treatment technologies.[5]

For other types of malignant gliomas, such as anaplastic astrocytomas, the prognosis tends to be somewhat better. The median age at diagnosis for glioblastoma is 64 years, while for anaplastic gliomas it is around 45 years. This difference in age at diagnosis reflects the distinct biological behavior of these tumor types.[3]

Survival statistics, while important for understanding the general course of the disease, represent averages across large groups of patients. Individual experiences can differ considerably. Some people may live longer than the median survival time, while others may face a more rapid progression. Factors such as the presence of certain genetic markers in the tumor cells can influence how well someone responds to treatment and how long they might live.[9]

⚠️ Important
When discussing prognosis, it is essential to remember that statistics provide general guidance but cannot predict an individual’s exact outcome. Each person’s tumor has unique characteristics, and advances in treatment continue to emerge. Having open, honest conversations with your medical team about your specific situation can help you understand what to expect and plan accordingly.

The five-year survival rate for glioblastoma remains quite low, ranging from 5 to 13 percent. This means that only a small percentage of people diagnosed with this condition will still be alive five years after their diagnosis. These numbers reflect the aggressive nature of these tumors and the challenges they pose to current medical treatments.[18]

Despite these challenging statistics, it is important to recognize that some people do become long-term survivors. Treatment advances, participation in clinical trials, and individual variations in tumor biology all contribute to different outcomes. Understanding prognosis helps patients and families prepare for the future while maintaining realistic hope.[16]

Natural Progression Without Treatment

Understanding how malignant gliomas behave when left untreated helps explain why prompt medical intervention is considered so critical. These tumors do not remain static; rather, they follow a pattern of continuous, often rapid growth that can have devastating consequences for brain function and overall health.[3]

Malignant gliomas are characterized by their diffuse infiltrative nature. This means that unlike some tumors that grow as distinct masses with clear boundaries, malignant gliomas send microscopic extensions of cancer cells into the surrounding healthy brain tissue. These invisible tendrils of tumor cells spread through the brain like roots, making it virtually impossible to completely remove all cancer cells even with the most skilled surgery.[7]

As the tumor grows, it occupies increasing amounts of space within the rigid skull, which cannot expand to accommodate the extra tissue. This creates pressure on the brain, leading to progressive worsening of symptoms. The tumor also disrupts normal brain structures and pathways, interfering with the brain’s ability to control various body functions and cognitive processes.[1]

Without treatment, a malignant glioma will continue to grow and spread within the brain and spinal cord. The tumor may extend to the opposite side of the brain through connecting structures such as the corpus callosum, which normally allows the two brain hemispheres to communicate. It can also spread through the fluid-filled spaces in the brain called ventricles. However, it is exceedingly rare for these tumors to spread outside the brain and spinal cord to other parts of the body.[7]

The rate of progression varies depending on the specific type of malignant glioma. Glioblastomas grow very quickly, and symptoms typically worsen over weeks to months without intervention. Lower-grade malignant gliomas may progress more slowly, but they eventually transform into higher-grade tumors if left untreated.[10]

As the disease advances, the affected person experiences increasingly severe neurological deterioration. This may include worsening headaches, more frequent or severe seizures, progressive weakness or paralysis, deepening confusion, and eventually loss of consciousness. The tumor’s growth ultimately interferes with vital brain functions necessary for survival, such as breathing and heart rate regulation.[11]

The natural history of untreated malignant glioma underscores why medical teams recommend starting treatment as soon as possible after diagnosis. While treatment cannot cure the disease in most cases, it can slow the tumor’s growth, reduce symptoms, and extend survival while maintaining a better quality of life than would occur without any intervention.[13]

Possible Complications of Malignant Glioma

Beyond the primary challenge of the tumor itself, malignant gliomas can give rise to numerous complications that significantly impact health and daily functioning. These complications may arise from the tumor’s direct effects on the brain, from treatments used to fight the disease, or from the body’s response to having cancer.[2]

One of the most common and troubling complications is seizures, which occur when abnormal electrical activity spreads through the brain tissue affected by the tumor. Seizures can range from brief episodes of staring or confusion to violent convulsions involving the entire body. They may occur at any time and can be frightening for both the person experiencing them and those nearby. Even with anti-seizure medications, seizures may not be fully controlled in all cases.[11]

Increased pressure within the skull, known as intracranial pressure, develops as the tumor grows and takes up more space. This pressure can cause severe headaches that are typically worse in the morning, nausea and vomiting, drowsiness, and changes in mental status. If pressure becomes very high, it can be life-threatening because it may compress vital structures in the brain that control breathing and consciousness.[1]

Cognitive and mental changes represent another significant category of complications. People with malignant gliomas may experience difficulties with memory, attention, problem-solving, and learning new information. These cognitive deficits can range from subtle difficulties that only the person notices to severe impairment that makes independent living impossible. Personality changes, mood swings, depression, and anxiety are also common and can be distressing for both patients and their loved ones.[17]

Physical disabilities often develop as the tumor affects brain regions responsible for movement and coordination. Depending on the tumor’s location, a person might develop weakness or paralysis on one side of the body, called hemiparesis, or lose the ability to walk, balance, or perform fine motor tasks. These physical limitations can make everyday activities like dressing, eating, and personal care extremely challenging.[2]

Speech and communication problems occur when tumors affect language centers in the brain. This condition, called aphasia, may make it difficult to speak, understand others, read, or write. The inability to communicate effectively can be profoundly isolating and frustrating for patients and creates additional stress for family members trying to provide care.[11]

Vision problems arise when tumors grow near or compress the pathways that carry visual information through the brain. People may experience blurred vision, double vision, loss of peripheral vision, or even complete blindness in one or both eyes. These visual impairments add another layer of disability and safety concern to daily life.[1]

Treatment-related complications must also be considered. Surgery can cause bleeding, infection, or new neurological deficits if important brain structures are unavoidably affected during tumor removal. Radiation therapy can damage healthy brain tissue over time, leading to cognitive decline, hormone deficiencies if the pituitary gland is affected, and increased risk of stroke. Chemotherapy can cause fatigue, nausea, low blood counts that increase infection risk, and other side effects.[9]

Blood clots in the legs, called deep vein thrombosis, occur more frequently in people with brain tumors, partly due to reduced mobility. These clots can travel to the lungs, causing a potentially fatal complication called pulmonary embolism. Infections also pose greater risks, as treatments that fight cancer can weaken the immune system.[13]

Impact on Daily Life

Living with a malignant glioma affects virtually every aspect of a person’s daily existence. The disease and its treatments create ripples that extend through all dimensions of life, from the most basic physical activities to complex emotional and social interactions. Understanding these impacts helps patients and families prepare for the changes ahead and seek appropriate support.[17]

Physical limitations often become one of the most immediately apparent changes. Many people with malignant gliomas experience profound fatigue that goes beyond ordinary tiredness. This cancer-related fatigue can make even simple tasks feel exhausting and may not improve with rest. The fatigue, combined with other physical symptoms like weakness, balance problems, or headaches, can make it difficult or impossible to continue working, especially in physically demanding jobs.[18]

Cognitive changes affect the ability to think clearly, remember information, and make decisions. These difficulties can interfere with work that requires concentration, learning, or problem-solving. Many people find they can no longer manage complex tasks they previously handled easily, such as managing finances, following recipes, or navigating to unfamiliar places. Students may struggle to keep up with coursework, while working adults may need to reduce their hours or stop working entirely.[17]

The emotional and psychological impact of malignant glioma can be overwhelming. Receiving a diagnosis of an aggressive brain tumor naturally triggers anxiety, fear, and grief. Depression is common and may be both a psychological response to the diagnosis and a direct result of the tumor’s effects on brain regions that regulate mood. Personality changes may occur, causing people to behave in ways that seem unlike their usual character, which can strain relationships with family and friends.[2]

Independence often becomes compromised as the disease progresses. People who once valued their self-sufficiency may need help with personal care, transportation, meal preparation, and household tasks. The loss of the ability to drive, which often occurs due to seizures or other neurological symptoms, can be particularly devastating, as it represents both a practical limitation and a symbol of lost autonomy.[11]

Social relationships undergo significant changes. Friends may not know how to respond to the diagnosis and may withdraw, leaving patients feeling isolated at a time when they most need support. Social activities that were once enjoyable may become difficult or impossible due to physical limitations, fatigue, or cognitive changes. The person with glioma may feel different from their peers and struggle to maintain connections.[24]

Family dynamics shift dramatically when someone is diagnosed with malignant glioma. Spouses or partners often take on caregiving responsibilities while dealing with their own emotional distress. Children may struggle to understand what is happening to their parent and may experience behavioral or emotional difficulties. Financial stress frequently adds to the burden, as medical bills accumulate while income may decrease if the patient or their caregiver can no longer work full-time.[18]

Hobbies and leisure activities that once brought joy may need to be abandoned or modified. Physical activities like sports or gardening may become too difficult. Cognitive hobbies like reading or puzzles may become frustrating if concentration or memory is impaired. This loss of meaningful activities can contribute to depression and reduced quality of life.[17]

⚠️ Important
While malignant glioma creates significant challenges to daily life, many people find ways to adapt and maintain quality of life. Occupational therapy can help with practical strategies for managing daily activities. Counseling or support groups provide emotional outlets. Open communication with healthcare providers about symptoms and concerns enables better management of problems as they arise. Focusing on what remains possible, rather than only on what has been lost, can help maintain a sense of purpose and hope.

Treatment schedules themselves can be disruptive to daily life. Radiation therapy typically requires daily visits to a treatment center for several weeks. Chemotherapy appointments, managing side effects, and frequent medical appointments for monitoring can make it difficult to maintain normal routines. The demands of treatment can be exhausting and time-consuming for both patients and their caregivers.[9]

Despite these challenges, many people with malignant gliomas find ways to maintain meaningful aspects of their lives. Adapting expectations, accepting help from others, and focusing on quality of life rather than quantity can help people continue to find purpose and connection even as they face a serious illness. Support from family, friends, healthcare providers, and others who understand what they are going through can make an enormous difference in coping with the disease’s impact on daily living.[18]

Support for Family Members

When someone is diagnosed with malignant glioma, the impact extends far beyond the patient themselves. Family members face their own journey of adjustment, grief, and challenge as they support their loved one while managing their own emotional needs. Understanding what families experience and how they can help, particularly regarding clinical trials, is essential for comprehensive care.[24]

Family members often become caregivers, taking on responsibilities that can be both physically and emotionally demanding. They may need to help with personal care, administer medications, coordinate medical appointments, and monitor for changes in symptoms. This caregiving role can be overwhelming, especially when combined with their own jobs, household responsibilities, and concerns about the future. Caregivers frequently experience high levels of stress, anxiety, and depression, and may neglect their own health needs while focusing on their loved one.[24]

Understanding clinical trials is an important aspect of supporting someone with malignant glioma. Because standard treatments for malignant gliomas have limited effectiveness, many patients and families consider participating in research studies that test new approaches. Clinical trials are carefully designed research studies that evaluate whether new treatments are safe and effective. They represent the primary way that medical science develops better treatments for these aggressive tumors.[9]

Families can help their loved one explore clinical trial options by researching what trials are available and whether the patient meets the eligibility requirements. Many trials have specific criteria regarding tumor type, grade, previous treatments received, and overall health status. The medical team can provide information about trials available at their treatment center, but families can also search databases of clinical trials to find options at other institutions.[20]

Preparing for clinical trial participation involves understanding what the study entails, including what treatments will be given, what tests and procedures are required, how often visits to the treatment center are needed, and what potential risks and benefits exist. Families should help their loved one ask thorough questions of the research team and understand that participation is always voluntary. People can withdraw from a clinical trial at any time if they choose to do so.[9]

Practical support from family members includes helping with transportation to appointments, which may be frequent during clinical trial participation. Keeping organized records of medications, test results, and appointments helps ensure nothing is overlooked. Family members can serve as extra ears during medical consultations, helping remember information that the patient might miss or forget due to cognitive effects of the disease.[24]

Emotional support is equally important as practical help. Simply being present, listening without trying to fix everything, and acknowledging the difficulty of the situation can provide comfort. Families should avoid the temptation to maintain false optimism or dismiss the patient’s fears and concerns. Instead, honest conversations that respect the reality of the situation while still maintaining hope for the best possible outcome tend to be most helpful.[24]

Family members need to recognize their own limits and seek support for themselves. This might include joining caregiver support groups, seeking counseling, accepting help from friends and extended family, or using respite care services that provide temporary relief from caregiving responsibilities. Taking care of themselves is not selfish; rather, it enables them to provide better support over the long term.[24]

Communication within the family is crucial. Different family members may have different coping styles and emotional needs. Some may want detailed medical information while others prefer less detail. Some may want to talk openly about fears and sadness while others prefer to maintain a more positive focus. Respecting these differences while finding ways to stay connected as a family unit helps everyone navigate the challenges together.[24]

Financial and legal planning becomes important, though it can be difficult to address. Families may need to help their loved one organize financial affairs, update legal documents like wills and advance directives, and navigate insurance and disability benefits. While these tasks can feel overwhelming, addressing them proactively can prevent additional stress later and ensure the patient’s wishes are honored.[24]

Finally, families should remember that supporting someone with malignant glioma is not something they need to do alone. Healthcare teams, social workers, patient advocacy organizations, religious communities, and others can provide assistance, information, and emotional support. Reaching out for help is a sign of strength and wisdom, not weakness.[24]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Temozolomide – An oral chemotherapy drug given concurrently with radiation therapy and as adjuvant treatment for malignant gliomas, particularly glioblastoma
  • Carmustine (BCNU) – A nitrosourea chemotherapy agent used as adjuvant treatment, sometimes delivered via wafers implanted during surgery
  • Lomustine (CCNU) – A nitrosourea chemotherapy drug used in combination regimens for malignant gliomas
  • Procarbazine – A chemotherapy drug used in combination with lomustine and vincristine (PCV-3 therapy) for treating anaplastic gliomas
  • Vincristine – A chemotherapy agent used as part of combination therapy (PCV-3) for anaplastic astrocytomas and oligodendrogliomas
  • Hydroxycarbamide (Hydroxyurea) – A chemoradiopotentiator given alongside radiation therapy to improve survival outcomes

Ongoing Clinical Trials on Malignant glioma

  • Study Comparing Lomustine Alone and Lomustine with Bevacizumab for Patients with Recurrent Glioblastoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany The Netherlands
  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study of ONC201 for Patients with Newly Diagnosed H3 K27M-mutant Diffuse Glioma After Radiotherapy

    Recruiting

    1 1
    Investigated diseases:
    Austria Denmark Germany Italy The Netherlands Spain
  • Study on ONC201 and Paxalisib for Children and Young Adults with Diffuse Midline Gliomas, Including Diffuse Intrinsic Pontine Gliomas

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety of Photodynamic Therapy with Aminolevulinic Acid Hydrochloride for Patients Aged 18-75 with Grade IV Glioblastoma

    Not recruiting

    1 1
    Investigated diseases:
    France
  • Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland France +10

References

https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc-20350251

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://pmc.ncbi.nlm.nih.gov/articles/PMC4852970/

https://www.nicklauschildrens.org/conditions/malignant-glioma

https://genesdev.cshlp.org/content/15/11/1311

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/glioma-adults

https://www.abta.org/tumor_types/glioblastoma-gbm/

https://braintumourresearch.org/pages/types-of-brain-tumours-glioma?srsltid=AfmBOorqvuFIYlcORI8ixjO6FPW56jXFfxSQz2EKaj5F_3teQQKl9hDO

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://pmc.ncbi.nlm.nih.gov/articles/PMC4852970/

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.mskcc.org/cancer-care/types/glioma/glioma-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC1304839/

https://www.brighamandwomens.org/neurosurgery/videos/advancing-malignant-gliomas-treatment-video-transcript

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/glioblastoma

https://www.aaroncohen-gadol.com/en/patients/glioma/survival/end-of-life

https://braintumor.org/news/lets-talk-about-glioblastoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8146925/

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.cancer.gov/news-events/cancer-currents-blog/2023/low-grade-glioma-optimum

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://www.abta.org/tumor_types/glioblastoma-gbm/

https://glioblastomafoundation.org/news/malignant-brain-tumor

https://www.thebraintumourcharity.org/living-with-a-brain-tumour/relationships/supporting-friends-and-family/support-family-and-friends/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What is the difference between malignant glioma and glioblastoma?

Glioblastoma is a specific type of malignant glioma and represents the most aggressive form. Malignant gliomas are a broader category that includes glioblastoma (grade 4), anaplastic astrocytoma, anaplastic oligodendroglioma, and mixed anaplastic oligoastrocytoma (all grade 3). Glioblastomas account for approximately 60-70% of all malignant gliomas.

How quickly do malignant gliomas grow?

Malignant gliomas are rapidly progressive tumors that grow quickly compared to low-grade brain tumors. Glioblastomas grow very quickly, with symptoms typically worsening over weeks to months. Other malignant gliomas like anaplastic astrocytomas may progress somewhat more slowly but are still considered fast-growing tumors that require prompt treatment.

Can malignant gliomas spread to other parts of the body?

It is exceedingly rare for malignant gliomas to spread outside the brain and spinal cord to other parts of the body. These tumors primarily spread within the brain itself and may extend to the opposite side of the brain through connecting structures or spread through the fluid-filled ventricles, but they do not typically metastasize to organs like other cancers.

What age group is most affected by malignant gliomas?

Malignant gliomas most commonly affect adults, with peak incidence in the fifth and sixth decades of life. The median age at diagnosis for glioblastoma is 64 years, while for anaplastic gliomas it is around 45 years. However, malignant gliomas can affect people at any age, including children, though they are less common in younger populations.

Are there any genetic factors that increase the risk of malignant glioma?

Some genetic syndromes are associated with increased risk of malignant gliomas, and certain gene polymorphisms affecting detoxification, DNA repair, and cell cycle regulation have been implicated in their development. However, most malignant gliomas are not clearly linked to inherited genetic factors. If brain tumors run in your family, you may want to discuss genetic counseling with your healthcare provider.

🎯 Key takeaways

  • Malignant gliomas are rapidly growing brain tumors with median survival of 9-12 months for glioblastoma despite maximum treatment
  • These tumors grow by both forming masses and infiltrating surrounding brain tissue with microscopic extensions that are invisible to the eye
  • Treatment requires a multidisciplinary approach combining surgery, radiation therapy, and chemotherapy, individually adjusted for each patient
  • Common symptoms include headaches, seizures, cognitive changes, personality alterations, vision problems, and weakness on one side of the body
  • Clinical trials represent important opportunities to access new treatments as standard therapies have limited effectiveness
  • The disease profoundly affects daily life including work capacity, independence, social relationships, and emotional well-being
  • Family members play crucial roles as caregivers and need their own support systems to manage the physical and emotional demands
  • While prognosis is generally poor, individual outcomes vary based on tumor characteristics, genetic markers, age, and treatment response